Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in NUVB — Nuvation Bio Inc.

CIK 73124 CHICAGO, IL
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,188,237
+$4,594,906 QoQ
Shares Held
2,321,873
+15.9% QoQ
Ownership
0.661%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. NUVB ranks #103 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,188,237 2,321,873
2026-03-31 $8,593,331 2,003,108
2025-12-31 $17,218,716 1,921,732
2025-09-30 $7,835,384 2,117,672
2025-06-30 $4,064,123 2,084,167
2025-03-31 $3,549,326 2,016,665
2024-12-31 $5,550,756 2,086,751
2024-09-30 $3,487,952 1,523,124
2024-06-30 $3,700,558 1,267,315
2024-03-31 $4,482,065 1,231,337
2023-12-31 $1,842,556 1,220,237
2023-09-30 $1,743,117 1,300,835
2023-06-30 $2,252,760 1,251,534
2023-03-31 $1,780,426 1,072,547
2022-12-31 $2,049,642 1,067,523
2022-09-30 $2,302,781 1,028,028
2022-06-30 $3,357,591 1,036,294
2022-03-31 $7,175,160 1,364,099
2021-12-31 $12,031,291 1,415,446
2021-09-30 $7,413,042 745,779
2021-06-30 $4,467,513 479,862
2021-03-31 $1,238,972 118,562